title: Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia.
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Antonioli
authors.forename: Alessandra
authors.initials: A
authors.lastname: Carobbio
authors.forename: Lisa
authors.initials: L
authors.lastname: Pieri
authors.forename: Alessandro
authors.initials: A
authors.lastname: Pancrazzi
authors.forename: Paola
authors.initials: P
authors.lastname: Guglielmelli
authors.forename: Federica
authors.initials: F
authors.lastname: Delaini
authors.forename: Vanessa
authors.initials: V
authors.lastname: Ponziani
authors.forename: Niccolò
authors.initials: N
authors.lastname: Bartalucci
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Tozzi
authors.forename: Alberto
authors.initials: A
authors.lastname: Bosi
authors.forename: Alessandro
authors.initials: A
authors.lastname: Rambaldi
authors.forename: Tiziano
authors.initials: T
authors.lastname: Barbui
authors.forename: Alessandro M
authors.initials: AM
authors.lastname: Vannucchi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D019943:Amino Acid Substitution; D005260:Female; D005787:Gene Frequency; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D019384:Nucleic Acid Synthesis Inhibitors / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics*; D013920:Thrombocythemia, Essential / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D019384:Nucleic Acid Synthesis Inhibitors; D053614:Janus Kinase 2; D006918:Hydroxyurea